Abstract
The M2 muscarinic acetylcholine receptor belongs to the family of rhodopsin like G-Protein Coupled Receptors. This subtype of muscarinic receptors is of special interest because it bears, aside from an orthosteric binding site, also an allosteric binding site. Based on the X-ray structure of bovine rhodopsin a complete homology model of the human M2 receptor was developed. For the orthosteric binding site point mutations and binding studies with different agonists and antagonists are available. This knowledge was utilized for an initial verification of the M2 model. Allosteric modulation of activity is mediated by structurally different ligands such as gallamine, caracurine V salts or W84 (a hexamethonium-derivative). Caracurine V derivatives with different affinities to M2 were docked using GRID-fields. Subsequent molecular dynamics simulations yielded different binding energies based on diverse electrostatic and lipophilic interactions. The calculated affinities are in good agreement to experimentally determined affinities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le Trong, I., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M. and Miyano, M., Science, 289 (2000), 739.
Bairoch A. and Apweiler R., Nucleic Acids Res., 28 (2000), 45.
Gasteiger E., Jung E. and Bairoch A., Curr. Issues Mol. Biol., 3 (2001), 47.
McGuffin, L.J., Bryson K. and Jones, D.T., Bioinformatics, 16 (2000), 404.
Jones, D.T., J. Mol. Biol., 292 (1999), 195.
Jones, D.T., Taylor, W.R. and Thornton, J.M. Biochem., 33 (1994), 3038.
Baldi, P., Brunak, S., Frasconi, P., Pollastri, G. and Soda, G., Bioinformatics, 15 (1999), 937.
Baldwin, J.M., Schertler, G.F.X. and Unger, V.M., J. Mol. Biol., 272 (1997), 144.
Cuff, J.A. and Barton G.J.,Proteins: Structure, Function and Genetics, 40 (1999), 502.
LOOPP: http://ser-loopp.tc.cornell.edu/loopp.html.
Insight II 2000, Accelrys Inc., San Diego, U.S.A.
Juretic D., Zoranic, L. and Zucic, D., J. Chem. Inf. Comp. Sci., accepted for publication.
Laskowski, R.A. MacArthur, M.W. Moss, D.S. and Thornton, J.M., J. Appl. Cryst., 26 (1993), 283.
Morris, A.L., MacArthur, M.W., Hutchinson, E.G. and Thornton, J.M., Proteins, 12 (1992), 345.
FDiscover, Accelrys, San Diego, U.S.A.
Heitz, F., Trumpp-Kallmeyer, S. and Hibert, M.F., Eur. J. Pharmacol., 380 (1999), 183.
Goodford P.J., J. Med. Chem., 28 (1985),849.
Gnagey, A., Seidenberg, M. and Ellis, J., Mol. Pharmacol., 56 (1999), 1245.
Buller, S., Zlotos, D.P., Mohr, K. and Ellis, J., Mol. Pharmacol., 61 (2002), 160.
Zlotos, D.P., Buller, S., Tränkle, C. and Mohr K., Bioorg. Med. Chem. Lett., 10 (2000), 2529.
Laskowski, R.A., J. Mol. Graph., 13 (1995), 323.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jöhren, K., Höltje, HD. A model of the human M2 muscarinic acetylcholine receptor. J Comput Aided Mol Des 16, 795–801 (2002). https://doi.org/10.1023/A:1023880611709
Issue Date:
DOI: https://doi.org/10.1023/A:1023880611709